Ira Weinstein

BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.

Part of Forticell Bioscience, Inc., Hapto Biotech Ltd. develops and manufactures biological products for tissue repair and regeneration. The company is based in Jerusalem, Israel. Hapto Biotech was acquired by Forticell Bioscience, Inc. on April 17, 2006 for $9.41 million.

InCure Ltd. is a start-up biotechnology company developing an early detection immunological kit of solid carcinoma invasion and metastasis. A critical event in malignant tumor development is the acquisition of the ability to invade through basement membranes and then reemerge from the blood vessels to establish new metastatic colonies at distant sites

Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA.